Related Experiment Video
Updated: May 11, 2026
08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Induced pluripotent stem cell modeling of complex genetic diseases
J Travis Hinson1, Kenta Nakamura, Sean M Wu
1Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
Drug Discovery Today. Disease Models
|May 22, 2013
Summary
Human induced pluripotent stem cells offer a promising avenue for understanding complex disease genetics. These cells can help bridge the gap between genetic variants and disease mechanisms, advancing complex disease modeling.
Area of Science:
- Genetics
- Stem Cell Biology
- Genomics
Background:
- Genome-wide association studies (GWAS) have identified numerous human genomic loci linked to complex diseases.
- The functional roles of most identified genetic loci remain largely unknown, hindering mechanistic understanding.
Purpose of the Study:
- To explore the potential of human induced pluripotent stem (iPS) cells for elucidating the functional consequences of genetic variants in complex diseases.
- To discuss the application of iPS cell technology in modeling complex diseases and identify associated challenges.
Main Methods:
- Review of current literature on GWAS, complex disease genetics, and iPS cell applications.
- Discussion of specific disease examples where iPS cells could be utilized for mechanistic studies.
Main Results:
- Human iPS cells present a viable model system to connect genetic associations with biological mechanisms.
- The potential exists to model complex human diseases using patient-derived iPS cells.
Conclusions:
- iPS cell technology holds significant promise for advancing the study of complex disease genetics.
- Overcoming current technological and practical roadblocks is essential for the widespread adoption of iPS cells in complex disease modeling.
More Related Videos
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.